Lein M - Search Results

1

The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.

Lein M, Koenig F, Jung K, McGovern FJ, Skates SJ, Schnorr D, Loening SA. Lein M, et al. Br J Urol. 1998 Aug;82(2):231-6. doi: 10.1046/j.1464-410x.1998.00723.x. Br J Urol. 1998. PMID: 9722758

2

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.

Stephan C, Jung K, Diamandis EP, Rittenhouse HG, Lein M, Loening SA. Stephan C, et al. Among authors: lein m. Urology. 2002 Jan;59(1):2-8. doi: 10.1016/s0090-4295(01)01449-2. Urology. 2002. PMID: 11796270 Review. No abstract available.

3

An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation.

Stephan C, Jung K, Cammann H, Vogel B, Brux B, Kristiansen G, Rudolph B, Hauptmann S, Lein M, Schnorr D, Sinha P, Loening SA. Stephan C, et al. Among authors: lein m. Int J Cancer. 2002 May 20;99(3):466-73. doi: 10.1002/ijc.10370. Int J Cancer. 2002. PMID: 11992419

4

A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations.

Lein M, Kwiatkowski M, Semjonow A, Luboldt HJ, Hammerer P, Stephan C, Klevecka V, Taymoorian K, Schnorr D, Recker F, Loening SA, Jung K. Lein M, et al. J Urol. 2003 Oct;170(4 Pt 1):1175-9. doi: 10.1097/01.ju.0000087560.30497.4e. J Urol. 2003. PMID: 14501719

5

Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer.

Jung K, Stephan C, Semjonow A, Lein M, Schnorr D, Loening SA. Jung K, et al. Among authors: lein m. J Urol. 2003 Dec;170(6 Pt 1):2302-5. doi: 10.1097/01.ju.0000094191.39574.cb. J Urol. 2003. PMID: 14634401

6

A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigen.

Lein M, Semjonow A, Graefen M, Kwiatkowski M, Abramjuk C, Stephan C, Haese A, Chun F, Schnorr D, Loening SA, Jung K. Lein M, et al. J Urol. 2005 Dec;174(6):2150-3. doi: 10.1097/01.ju.0000181221.72017.ca. J Urol. 2005. PMID: 16280753 Clinical Trial.

7

New insights into the diagnostic accuracy of complexed and total prostate specific antigen using discordance analysis characteristics.

Jung K, Lein M, Butz H, Stephan C, Loening SA, Keller T. Jung K, et al. Among authors: lein m. J Urol. 2006 Apr;175(4):1275-80. doi: 10.1016/S0022-5347(05)00707-X. J Urol. 2006. PMID: 16515979

8

A (-5, -7) proPSA based artificial neural network to detect prostate cancer.

Stephan C, Meyer HA, Kwiatkowski M, Recker F, Cammann H, Loening SA, Jung K, Lein M. Stephan C, et al. Among authors: lein m. Eur Urol. 2006 Nov;50(5):1014-20. doi: 10.1016/j.eururo.2006.04.011. Epub 2006 May 2. Eur Urol. 2006. PMID: 16697520

9

Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics.

Jung K, Hoesel W, Reiche J, Deger S, Kramer J, Loening SA, Lein M, Stephan C. Jung K, et al. Among authors: lein m. Urology. 2007 Feb;69(2):320-5. doi: 10.1016/j.urology.2006.09.066. Urology. 2007. PMID: 17320672

10

Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.

Stephan C, Cammann H, Deger S, Schrader M, Meyer HA, Miller K, Lein M, Jung K. Stephan C, et al. Among authors: lein m. Urology. 2009 Oct;74(4):873-7. doi: 10.1016/j.urology.2009.02.054. Epub 2009 May 24. Urology. 2009. PMID: 19476981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters